Advarra OnCore vs. Stemcentrx

Advarra OnCore

4 Reviews and Ratings

Stemcentrx

Overview
Product	Rating	Most Used By	Product Summary	Starting Price
Advarra OnCore	Score2 out of 10	N/A	OnCore, from Advarra in Columbia (formerly known as Forte Research Systems) provides automated clinical research support featuring, billing and financial management, specimen management, reporting, effort tracking, and integration into other clinical systems.	N/A
Stemcentrx	N/A	N/A	Stemcentrx develops therapies that aim to cure and significantly improve survival for cancer patients. They are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed the company to advance from target discovery in laboratory to treating patients in clinical trials.	N/A

Pricing

Advarra OnCore

Stemcentrx

No answers on this topic

No answers on this topic

Pricing Offerings
Advarra OnCore	Stemcentrx
Free Trial
No	No
Free/Freemium Version
No	No
Premium Consulting/Integration Services
No	No

No setup fee

No setup fee

—

—

User Ratings
	Advarra OnCore	Stemcentrx
Likelihood to Recommend	9.0 (1 ratings)	- (0 ratings)

User Testimonials
	Advarra OnCore	Stemcentrx
Likelihood to Recommend	Advarra (formerly Forte Research System) Advarra is well suited for monitoring the progress of the clinical trials for a research organization. It's biggest advantage is the fact that the participants details and accrual monitoring shows the progress of the clinical trial. OnCore provides the capability of creating and using study calendars and especially monitoring and tracking participants visits. OnCore may be less appropriate to use in regards to grants and funds tracking. Incentivized Verified User Read full review	Stemcentrx, Inc. No answers on this topic
Alternatives Considered	Advarra (formerly Forte Research System) I have not used nor evaluated any other products similar to Advarra OnCore. Did not participate in the selection process. Incentivized Verified User Read full review	Stemcentrx, Inc. No answers on this topic
ScreenShots